In vitro & in vivo evaluations of PLGA nanoparticle based combinatorial drug therapy for baclofen and lamotrigine for neuropathic pain management

References

• Aucoin, H.R., et al., 2013. Release of potassium ion and calcium ion from phosphorylcholine group bearing hydrogels. Polymers, 5 (4), 1241–1257.
   Web of Science ®Google Scholar
• Barcia, J.J., 2007. The Giemsa stain: its history and applications. International journal of surgical pathology, 15 (3), 292–296.
   PubMed Web of Science ®Google Scholar
• Bilati, U., Allémann, E., and Doelker, E., 2005. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. European journal of pharmaceutics and biopharmaceutics, 59 (3), 375–388.
   PubMed Web of Science ®Google Scholar
• Caraceni, A., and Portenoy, R.K., 1999. An international survey of cancer pain characteristics and syndromes. Pain, 82 (3), 263–274.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, M., Kumar, M., and Pathak, K., 2011. A review on mucoadhesive polymer used in nasal drug delivery system. Journal of advanced pharmaceutical technology & research, 2 (4), 215–222.
   PubMedGoogle Scholar
• Chong, E., and Dupuis, L.L., 2002. Therapeutic drug monitoring of lamotrigine. The annals of pharmacotherapy, 36 (5), 917–920.
   PubMed Web of Science ®Google Scholar
• Cojocaru, V., et al., 2015. Formulation and evaluation of in vitro release kinetics of Na3CaDTPA decorporation agent embedded in microemulsion-based gel formulation for topical delivery. Farmacia, 63 (5), 656–664.
   Web of Science ®Google Scholar
• Daousi, C., et al., 2004. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabetic medicine, 21 (9), 976–982.
   PubMed Web of Science ®Google Scholar
• Davies, K.G., et al., 2013. Effects of artemether and Artesunate on social behaviour and pain perception. Research in neuroscience, 2 (3), 31–38.
   Google Scholar
• Dinarello, C.A., 2000. Proinflammatory cytokines. Chest, 118 (2), 503–508.
   PubMed Web of Science ®Google Scholar
• Dong, X., 2018. Current strategies for brain drug delivery. Theranostics, 8 (6), 1481–1493.
   PubMed Web of Science ®Google Scholar
• Dubuisson, D., and Dennis, S.G., 1977. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 4 (2), 161–174.
   PubMed Web of Science ®Google Scholar
• Dworkin, R.H., et al., 2007. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain, 132 (3), 237–251.
   PubMed Web of Science ®Google Scholar
• Freeling, J.P., et al., 2015. Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates. AIDS research and human retroviruses, 31 (1), 107–114.
   PubMed Web of Science ®Google Scholar
• Gabhane, K., Jaiswal, A., and Tapar, K., 2014. Simple and validated ultraviolet spectrophotometric method for the estimation of baclofen in bulk form. Research journal of pharmaceutical, biological and chemical sciences, 5, 104–109.
   Google Scholar
• Gentile, P., et al., 2014. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. International journal of molecular sciences, 15 (3), 3640–3659.
   PubMed Web of Science ®Google Scholar
• Gupta, B., Chaurasia, U., and Chakraborty, P., 2014. Design and development of oral transmucosal film for delivery of salbutamol sulphate. Journal of pharmaceutical, chemical and biological sciences, 2 (2), 118–129.
   Google Scholar
• Halazynski, T.M., et al., 2009. Acute pain management for elderly high-risk and cognitively impaired patients: rationale for regional analgesia. Acute pain management, 1, 514–536.
   Google Scholar
• Hamilton, T.A., 2002. Molecular basis of macrophage activation: from gene expression to phenotypic diversity. The macrophage, 2, 73–102.
   Google Scholar
• Hanson, L.R., and Frey, W.H., 2008. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC neuroscience, 9 (S3), 1–4.
   PubMed Web of Science ®Google Scholar
• Hewitt, D.J., et al., 1997. Pain syndromes and etiologies in ambulatory AIDS patients. Pain, 70 (2–3), 117–123.
   PubMed Web of Science ®Google Scholar
• Kumar, M.K., et al., 2008. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. International journal of pharmaceutics, 358 (1–2), 285–291.
   PubMed Web of Science ®Google Scholar
• Kalimouttou, S., et al., 2009. Sinefungin-PLGA nanoparticles: drug loading, characterization, in vitro drug release and in vivo studies. Journal of nanoscience and nanotechnology, 9 (1), 150–158.
   PubMed Web of Science ®Google Scholar
• Kapuściński, J., and Skoczylas, B., 1978. Fluorescent complexes of DNA with DAPI 4',6-diamidine-2-phenyl indole.2HCl or DCI 4',6-dicarboxyamide-2-phenyl indole. Nucleic acids research, 5 (10), 3775–3800.
   PubMed Web of Science ®Google Scholar
• Kaur, A., et al., 2017. Intravaginal delivery of polyphenon 60 and curcumin nanoemulsion gel. AAPS pharmscitech, 18 (6), 2188–2202.
   PubMed Web of Science ®Google Scholar
• Keck, P.E., and McElroy, S.L., 2002. Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. Journal of clinical psychiatry, 63 (Suppl 4), 3–11.
   PubMed Web of Science ®Google Scholar
• Kehlet, H., Jensen, T.S., and Woolf, C.J., 2006. Persistent postsurgical pain: risk factors and prevention. The lancet, 367 (9522), 1618–1625.
   PubMed Web of Science ®Google Scholar
• Kingsley, J.D., et al., 2006. Nanotechnology: a focus on nanoparticles as a drug delivery system. Journal of neuroimmune pharmacology, 1 (3), 340–350.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Ali, J., and Baboota, S., 2016. Design Expert(®) supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson's disease. Nanotechnology, 27 (43), 435101.
   PubMed Web of Science ®Google Scholar
• Lalani, J., et al., 2015. Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management. AAPS pharmscitech, 16 (2), 413–427.
   PubMed Web of Science ®Google Scholar
• Lehto, S.G., et al., 2016. Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory-and neuropathic-induced mechanical hypersensitivity in rats. Molecular pain, 12, 1744806916677761.
   Web of Science ®Google Scholar
• Li, S.Y., et al., 2015. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells. Journal of controlled release, 205, 7–14.
   PubMed Web of Science ®Google Scholar
• Mantovani, A., et al., 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends in immunology, 25 (12), 677–686.
   PubMed Web of Science ®Google Scholar
• Martinac, A., et al., 2005. Spray-dried chitosan/ethylcellulose microspheres for nasal drug delivery: swelling study and evaluation of in vitro drug release properties. Journal of microencapsulation, 22 (5), 549–561.
   PubMed Web of Science ®Google Scholar
• Mendlik, M.T., and Uritsky, T.J., 2015. Treatment of neuropathic pain. Current treatment options in neurology, 17 (12), 1–15.
   Web of Science ®Google Scholar
• Mistry, A., Stolnik, S., and Illum, L., 2009. Nanoparticles for direct nose-to-brain delivery of drugs. International journal of pharmaceutics, 379 (1), 146–157.
   PubMed Web of Science ®Google Scholar
• Mohanraj, K., Sethuraman, S., and Krishnan, U.M., 2013. Development of poly(butylene succinate) microspheres for delivery of levodopa in the treatment of Parkinson's disease. Journal of biomedical materials research. Part B, applied biomaterials, 101 (5), 840–847.
   PubMed Web of Science ®Google Scholar
• Nigam, K., et al., 2019a. Baclofen-loaded poly (D,L-Lactide-Co-Glycolic Acid) nanoparticles for neuropathic pain management: in vitro and in vivo evaluation. Rejuvenation research, 22 (3), 235–245.
   PubMed Web of Science ®Google Scholar
• Nigam, K., et al., 2019b. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles. Drug delivery and translational research, 9 (5), 879–890.
   PubMed Web of Science ®Google Scholar
• Paisley, S., et al., 2002. Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review. Multiple sclerosis, 8 (4), 319–329.
   PubMed Web of Science ®Google Scholar
• Ranjan, A.P., et al., 2012. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. Journal of nanobiotechnology, 10 (1), 38.
   PubMed Web of Science ®Google Scholar
• Rastogi, R., et al., 2007. Alginate microspheres of isoniazid for oral sustained drug delivery. International journal of pharmaceutics, 334 (1–2), 71–77.
   PubMed Web of Science ®Google Scholar
• Rizzo, M.A., et al., 2004. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Multiple sclerosis, 10 (5), 589–595.
   PubMed Web of Science ®Google Scholar
• Romero-Pérez, A., et al., 2010. Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants. Veterinary research communications, 34 (1), 71–79.
   PubMed Web of Science ®Google Scholar
• Sharma, A., et al., 2012. Green tea extract: possible mechanism and antibacterial activity on skin pathogens. Food chemistry, 135 (2), 672–675.
   PubMed Web of Science ®Google Scholar
• Sharma, D., et al., 2016. Nose to brain delivery of midazolam loaded PLGA nanoparticles: in vitro and in vivo investigations. Current drug delivery, 13 (4), 557–564.
   PubMed Web of Science ®Google Scholar
• Sharma, D., et al., 2014. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. BioMed research international, 2014, 156010.
   PubMed Web of Science ®Google Scholar
• Sharma, D., et al., 2015. Nose-to-brain delivery of PLGA-diazepam nanoparticles. AAPS pharmscitech, 16 (5), 1108–1121.
   PubMed Web of Science ®Google Scholar
• Sharma, Y., et al., 2017. Inhibition of Src homology 2 domain containing protein tyrosine phosphatase as the possible mechanism of metformin-assisted amelioration of obesity induced insulin resistance in high fat diet fed C57BL/6J mice. Biochemical and biophysical research communications, 487 (1), 54–61.
   PubMed Web of Science ®Google Scholar
• Shinde, V.R., et al., 2008. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique. The journal of pharmacy and pharmacology, 60 (9), 1121–1129.
   PubMed Web of Science ®Google Scholar
• Siddall, P.J., et al., 2003. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain, 103 (3), 249–257.
   PubMed Web of Science ®Google Scholar
• Sindrup, S.H., et al., 2005. Antidepressants in the treatment of neuropathic pain. Basic & clinical pharmacology & toxicology, 96 (6), 399–409.
   PubMed Web of Science ®Google Scholar
• Srichaiya, A., et al., 2008. Bioequivalence of generic lamotrigine 100-mg tablets in healthy Thai male volunteers: a randomized, single-dose, two-period, two-sequence crossover study. Clinical therapeutics, 30 (10), 1844–1851.
   PubMed Web of Science ®Google Scholar
• Su, C., et al., 2015. Persistent pain alters AMPA receptor subunit levels in the nucleus accumbens. Molecular brain, 8 (1), 1–17.
   PubMed Web of Science ®Google Scholar
• Wang, A.Z., Langer, R., and Farokhzad, O.C., 2012. Nanoparticle delivery of cancer drugs. Annual review of medicine, 63, 185–198.
   PubMed Web of Science ®Google Scholar
• Wang, X., Chi, N., and Tang, X., 2008. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. European journal of pharmaceutics and biopharmaceutics, 70 (3), 735–740.
   PubMed Web of Science ®Google Scholar
• Zhang, C., et al., 2016. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma. Journal of controlled release, 226, 193–204.
   PubMed Web of Science ®Google Scholar